Zhi-Xin Huang

Dr. Zhi-Xin Huang

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
YHYing Huang
Ying Huang
ZWZhenzhen Wang
Zhenzhen Wang
ZHZhi-Xin Huang
Zhi-Xin Huang
ZLZhenguo Liu
Zhenguo Liu
Biomarkers are measurable substances that could be used as objective indicators for disease diagnosis, responses to treatments, and outcomes predictions. In this review, we summarized the data on a number of important biomarkers including glutamate, S100B, glial fibrillary acidic protein, receptor for advanced glycation end-products, intercellular adhesion molecule-1, von willebrand factor, matrix metalloproteinase-9, interleukin-6, tumor necrosis factor-a, activated protein C, copeptin, neuron-specific enolase, tau protein, gamma aminobutyric acid, blood glucose, endothelial progenitor cells, and circulating CD34-positive cells that could be potentially used to indicate the disease burden and/or predict clinical outcome of ischemic stroke. We examined the relationship between specific biomarkers and disease burden and outcomes and discussed the potential mechanisms underlying the relationship. The clinical significance and implications of these biomarkers were also discussed.

31 May 2013 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
WSWen Sun
Wen Sun
CYCuiping Yuan
Cuiping Yuan
WLWenhua Liu
Wenhua Liu
YLYongkun Li
Yongkun Li
ZHZhi-Xin Huang
Zhi-Xin Huang
XLXinfeng Liu
Xinfeng Liu
Objective: Risk factors for cerebral microbleeds (CMBs) in moyamoya disease (MMD) remain unknown, and whether the presence or distribution of CMBs is related to the subsequent hemorrhagic events needs to be confirmed. This study aimed to investigate the relationship between intracranial vascular morphology and the incidence/distribution patterns of CMBs as well as to determine the outcome in adult patients with MMD. Methods: Eighty-five consecutive adult patients with MMD were prospectively evaluated by 3.0-tesla high-intensity susceptibility-weighted magnetic resonance imaging and catheter-based digital subtraction angiography from June 2009 to January 2012. The differences in intracranial angiography (Suzuki stages, posterior cerebral artery stages, and angiographic features of the anterior choroidal and posterior communicating arteries) and clinical parameters (age, gender, hemorrhagic onset, antiplatelet treatment, systolic/diastolic blood pressure, diabetes, and plasma fibrinogen) among various CMB distribution patterns were analyzed with multinomial logistic regression. Moreover, after a median follow-up of 23 months, the relationship between CMB distribution patterns and subsequent intraventricular hemorrhage was also analyzed with Kaplan-Meier survival analysis and a Cox proportional hazards model. Results: Forty-five female and 40 male patients were finally enrolled in the study with an average age of 41.4 ± 12.7 years. Thirty-one CMB foci were detected in 24 (28.2%) patients. Most of the lesions (n = 22, 71.0%) were located in the region of deep and periventricular white matter (DPWM). Dilation and extension of anterior choroidal and posterior communicating arteries (AChA-PComA) was found to be an independent risk factor associated with the CMBs located in DPWM (p = 0.045; odds ratio 3.39, 95% CI 1.03-11.19). Patients with DPWM CMBs showed a statistically higher likelihood of subsequent intraventricular hemorrhage compared to patients without CMB foci and with CMBs in other regions (p = 0.014) during the follow-up period. Multivariable analysis suggested that DPWM CMBs were independent predictors of subsequent intraventricular hemorrhage (p = 0.028; hazard ratio 5.53, 95% CI 1.20-25.41). Conclusions: Dilation and extension of AChA-PComA is a determinant of CMBs involved in DPWM. CMBs in DPWM are probably predictors of subsequent intraventricular hemorrhage.

19 February 2019 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
ZHZhi-Xin Huang
Zhi-Xin Huang
XLXiao-Ling Lin
Xiao-Ling Lin
HLHai-Ke Lu
Hai-Ke Lu
XLXiao-Yu Liang
Xiao-Yu Liang
LFLi-Juan Fan
Li-Juan Fan
XLXin-Tong Liu
Xin-Tong Liu

1 November 2013 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
ZHZhi-Xin Huang
Zhi-Xin Huang
QYQin Yin
Qin Yin
WSWen Sun
Wen Sun
WZWusheng Zhu
Wusheng Zhu
YLYongkun Li
Yongkun Li
XLXinfeng Liu
Xinfeng Liu

3 September 2014 in International Journal of Stroke
Verified
Journal Article
Closed access
PDF file
ZDZuowei Duan
Zuowei Duan
WSWen Sun
Wen Sun
WLWenhua Liu
Wenhua Liu
LXLulu Xiao
Lulu Xiao
ZHZhi-Xin Huang
Zhi-Xin Huang
XLXinfeng Liu
Xinfeng Liu

23 December 2020 in Neurological Research
Verified
Journal Article
Closed access
ZHZhi-Xin Huang
Zhi-Xin Huang
HGHong-Qiu Gu
Hong-Qiu Gu
XYXin Yang
Xin Yang
CWChun-Juan Wang
Chun-Juan Wang
YWYong‐Jun Wang
Yong‐Jun Wang
ZPZi-Xiao Li PhD
Zi-Xiao Li PhD
Objective: We aimed to investigate factors related to in-hospital mortality (IHM) in acute ischemic stroke (AIS) patients. Methods: We prospectively investigated 827,314 patients who were admitted within 7 days of AIS between August 2015 and July 2019. Demographic characteristics, risk factors, and clinical and laboratory characteristics of patients were assessed. Univariate and multivariate logistic regression analyses were performed to identify predictors associated with IHM. Results: The IHM rate in this study was 0.5% in women and 0.3% in men. Factors associated with IHM in AIS included diabetes (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.03–1.43), female (OR 0.84, 95%CI 0.74–0.96), hypertension (OR 1.16, 95%CI 1.01–1.34), atrial fib/flutter (OR 1.51, 95%CI 1.29–1.77), other heart disease (OR1.43, 95%CI 1.23–1.67), prior myocardial infarction (OR 2.00, 95%CI 1.54–2.60), antiplatelet therapies (OR 0.71, 95%CI 0.60–0.84), gastrointestinal bleeding (OR 3.54, 95%CI 2.83–4.44), pulmonary embolism (OR 2.53, 95%CI1.41–4.53), dysphagia(OR7.32, 95%CI6.23–8.61), glycosylated hemoglobin (OR1.05, 95%CI 1.02–1.09), serum creatinine (OR 1.001, 95%CI 1.001–1.002), urea nitrogen (OR 1.10, 95%CI 1.08–1.12), National Institutes of Health Stroke Scale (NIHSS) score (4–5 vs. 0–4: OR 3.58; ≥15 vs. 0–4: OR 8.78), stroke rehabilitation (OR 0.27, 95%CI 0.23–0.30), age (third IQR vs. first IQR: OR 1.57; fourth IQR vs. first IQR: OR 2.23), and in-hospital stroke/TIArecurrence (OR 2.38, 95%CI 2.03–2.78). Conclusions: The findings from this study may help clinicians control the risk of IHM better for patients with AIS.